3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Dysplasia
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Diseases
1
Stomach Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Muscle-invasive Bladder Cancer
1
Mouth Neoplasms
1
Melanoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Acquired Immunodeficiency Syndrome
1
Interventions
Watchful Waiting
1
Telemedicine
1
Surveys and Questionnaires
1
Radiosurgery
1
Papillomavirus Vaccines
1
Observation
1
Motivational Interviewing
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Clinical Protocols
1
Carbon-14
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Papillomavirus Infections
×
Watchful Waiting
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled